ALK and cancer: For these analyses, we immunohistochemically evaluated the loss of E-cadherin expression (a well-known EMT marker) and two ALK-distinctive microRNAs (let-7e and miR-342-3p), which are associated to EMT and cancer cell migration and invasion [33, 34].